Global Robotic Medical Imaging Market Outlook by System Type.pdf

The Global Robotic Medical Imaging Market represents the worldwide industry that develops, manufactures, and sells robotic systems and related technologies designed to assist or automate imaging tasks in healthcare. These systems combine robotic arms, imaging equipment, artificial intelligence (AI), and software to improve diagnostic accuracy and procedural outcomes.
According to Credence Research The robotic medical imaging market size was valued at USD 8,762 million in 2024 and is anticipated to reach USD 24645.4 million by 2032, at CAGR of 13.8 % during the forecast period (2024-2032).

1. Global Robotic Medical Imaging Market Outlook
by System Type, Application, and End-Use, 2024–
2032
The Global Robotic Medical Imaging Market represents the worldwide industry that
develops, manufactures, and sells robotic systems and related technologies designed
to assist or automate imaging tasks in healthcare. These systems combine robotic
arms, imaging equipment, artificial intelligence (AI), and software to improve
diagnostic accuracy and procedural outcomes.
According to Credence Research The robotic medical imaging market size was valued
at USD 8,762 million in 2024 and is anticipated to reach USD 24645.4 million by 2032, at
CAGR of 13.8 % during the forecast period (2024-2032).
Source: https://www.credenceresearch.com/report/robotic-medical-imaging-market
The global robotic medical imaging market is poised for a period of transformative
growth, transitioning from a niche, innovative field to a mainstream clinical pillar. Driven
by the convergence of robotics, artificial intelligence (AI), and advanced imaging
modalities, this market addresses critical healthcare challenges like procedural
precision, workflow efficiency, and staff safety. Valued at approximately USD 2.5 - 3.0
billion in 2023, the market is projected to grow at a robust Compound Annual Growth
Rate (CAGR) of 10-13%, potentially reaching USD 6.5 - 8.5 billion by 2032. The
integration of AI for autonomous functions and data analysis will be the key accelerator
of this growth.
Market Overview & Current Landscape
Robotic medical imaging involves the use of robotic systems to position, operate, or
guide medical imaging equipment with a level of accuracy, stability, and repeatability
that surpasses human capability. These systems are revolutionizing diagnostic and
therapeutic procedures.
• Key Drivers:
o Demand for Higher Procedural Precision and Outcomes: In fields like
neurosurgery and oncology, sub-millimeter accuracy is critical.
o Workflow Optimization and Operational Efficiency: Robots reduce
setup time, automate repetitive tasks, and shorten procedure durations.
o Rising Adoption of Minimally Invasive Surgeries (MIS): Robotic imaging
is often integral to navigation and guidance in MIS.

2. o Growing Prevalence of Chronic Diseases: Cancer, cardiovascular, and
neurological disorders require sophisticated imaging for diagnosis and
treatment.
o Enhanced Safety for Patients and Staff: Robots can perform imaging in
environments unsafe for humans (e.g., high-radiation interventional
suites) and minimize human error.
• Key Restraints:
o Exceptionally High Capital Investment: The cost of acquiring and
installing robotic imaging systems is a significant barrier for many
hospitals.
o Regulatory Hurdles and Lengthy Approval Processes: Ensuring safety
and efficacy for these complex systems requires rigorous clinical
validation.
o Shortage of Skilled Professionals: Operating and maintaining these
advanced systems requires specialized training for surgeons, radiologists,
and technicians.
o Data Security and Integration Challenges: Integrating robotic systems
with existing hospital IT infrastructure (PACS, EHR) and ensuring
cybersecurity are complex tasks.
Market Segmentation & Outlook (2024–2032)
By System Type
This is the core technological segmentation of the market.
1. Robotic Computed Tomography (CT) Scanners:
o Outlook: Dominant and high-growth segment. Robots are used for
automated patient positioning and to guide interventional procedures
(biopsies, ablations) with real-time CT imaging.
o Example: Systems like Siemens Healthineers' SOMATOM for ICU
scanning or robotic arms used in interventional suites.
2. Robotic Magnetic Resonance Imaging (MRI) Systems:
o Outlook: High-growth potential, especially with the rise of MRI-guided
therapies. Robots enable precise targeting for biopsies and laser
ablations within the MRI bore, leveraging superior soft-tissue contrast.

3. o Example: MRI-guided focused ultrasound (MRgFUS) systems for treating
uterine fibroids and tremors.
3. Robotic Ultrasound Systems:
o Outlook: The fastest-growing segment. Robotic US automates
examinations, ensures consistent probe pressure, and enables tele-
ultrasound. It is widely used for repetitive screening and remote
diagnostics.
o Example: GE Healthcare's Vscan Air with robotic assist or systems from
Exact Imaging.
4. Robotic Positron Emission Tomography (PET) & Single-Photon Emission
Computed Tomography (SPECT):
o Outlook: Niche but critical. Used primarily in research and for
automated, high-throughput pre-clinical imaging. Growth is tied to
advancements in molecular imaging and drug development.
5. Hybrid Robotic Imaging Systems:
o Outlook: The future of the market. These systems combine multiple
modalities (e.g., PET-CT, SPECT-CT) with robotics for unparalleled
diagnostic and therapeutic capabilities, particularly in image-guided
radiation therapy (IGRT).
o Example: The Varian (Siemens Healthineers) Ethos™ therapy system,
which uses AI-driven adaptive radiotherapy guided by integrated imaging.
By Application
This defines the clinical purpose of the technology.
1. Neurology:
o Outlook: A major application area. Used for precise brain and spine
surgeries, stereotactic radiosurgery (e.g., Gamma Knife, CyberKnife), and
diagnostics of conditions like tumors and aneurysms. Demand is driven
by the complexity of neurological procedures.
2. Orthopedics:
o Outlook: Mature and rapidly expanding. Robotic C-arms and O-arms
provide intraoperative 3D imaging for spinal fusion, joint replacements,
and trauma surgery, ensuring perfect implant placement.
o Example: Medtronic's Mazor X system integrated with StealthStation
navigation.

4. 3. Oncology:
o Outlook: The largest and most critical application segment.
Encompasses early diagnosis (robotic biopsies), treatment planning
(precise tumor mapping), and therapy delivery (radiation therapy, tumor
ablation).
o Example: Accuray's CyberKnife system for stereotactic body radiation
therapy (SBRT).
4. Cardiology:
o Outlook: Significant growth potential. Used in robotic-assisted
catheterization for electrophysiology studies (EPS) and ablation
procedures, reducing radiation exposure to the cardiologist.
5. Gastroenterology & Others:
o Outlook: Emerging applications include robotic capsule endoscopy and
imaging for laparoscopic procedures.
By End-Use
This identifies where the systems are deployed.
1. Hospitals:
o Outlook: The largest end-use segment, accounting for over 60% of the
market. Large tertiary care and academic hospitals are the primary
adopters due to their high patient volume, complex caseload, and ability
to secure large capital budgets.
2. Ambulatory Surgical Centers (ASCs) & Specialty Clinics:
o Outlook: The fastest-growing end-use segment. As complex procedures
shift to outpatient settings, ASCs are increasingly investing in compact,
efficient robotic imaging systems to enhance their service offerings and
compete with hospitals.
3. Diagnostic Imaging Centers:
o Outlook: Steady growth. These centers adopt robotic systems,
particularly automated US and CT, to increase patient throughput, ensure
consistency in image quality, and offer advanced screening services.
4. Research & Academic Institutes:

5. o Outlook: A key segment for innovation. These institutions are early
adopters of cutting-edge technology for clinical research, drug discovery,
and the development of new surgical techniques.
Regional Forecast (2024–2032)
• North America:
o Position: Dominant market leader (~45% share).
o Drivers: High healthcare expenditure, rapid adoption of advanced
technology, favorable reimbursement policies, and the presence of major
market players (Siemens, GE, Johnson & Johnson).
• Europe:
o Position: Mature and significant market.
o Drivers: Strong government funding for healthcare technology, high
prevalence of chronic diseases, and a robust regulatory framework (CE
Mark).
• Asia-Pacific (APAC):
o Position: The fastest-growing region, expected to see the highest CAGR.
o Drivers: Massive and aging population, rising healthcare expenditure,
improving healthcare infrastructure, growing medical tourism, and
increasing investments from global players in countries like China, India,
and Japan.
• Rest of the World (Latin America, Middle East, Africa):
o Position: Emerging markets with gradual growth.
o Drivers: Growth is focused in wealthy Gulf nations and major urban
hospitals in Latin America, driven by targeted investments in modernizing
healthcare infrastructure.
Competitive Landscape
The market is characterized by intense competition and strategic partnerships.
• Key Players: Siemens Healthineers, GE HealthCare, Medtronic, Accuray Inc.,
Johnson & Johnson (Verb Surgical), Intuitive Surgical (integrated imaging),
Stryker, and Canon Medical Systems.
• Key Strategies:

6. o Product Innovation & Launches: Continuous development of more
compact, intelligent, and integrated systems.
o Mergers & Acquisitions (M&A): Companies acquiring tech startups to
gain AI and robotics capabilities.
o Strategic Collaborations: Partnerships between imaging giants and
robotics/AI firms to create best-in-class solutions.
o Geographic Expansion: Focusing on high-growth APAC markets.
Conclusion
The period from 2024 to 2032 will solidify robotic medical imaging's role as a
cornerstone of modern, value-based healthcare. The market's trajectory is not just
about robotic automation but about the creation of intelligent, data-driven, and
integrated clinical platforms. The synergy between robotics, AI, and imaging will
unlock new levels of diagnostic accuracy and therapeutic efficacy, making procedures
safer, faster, and more accessible, ultimately reshaping patient care on a global scale.